Viewing Study NCT03032406


Ignite Creation Date: 2025-12-26 @ 2:42 PM
Ignite Modification Date: 2026-03-04 @ 12:44 AM
Study NCT ID: NCT03032406
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-22
First Post: 2017-01-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
Sponsor: Abramson Cancer Center at Penn Medicine
Organization: